The ability to detect deceit generalizes across different types of high-stake lies.

PubWeight™: 1.59‹?› | Rank: Top 4%

🔗 View Article (PMID 9177024)

Published in J Pers Soc Psychol on June 01, 1997

Authors

M G Frank1, P Ekman

Author Affiliations

1: School of Communication, Information, and Library Studies, Rutgers, State University of New Jersey, New Brunswick 08901-1071, USA. mgfrunk@scils.rutgers.edu

Articles citing this

Human facial expressions as adaptations: Evolutionary questions in facial expression research. Am J Phys Anthropol (2001) 2.76

Signal characteristics of spontaneous facial expressions: automatic movement in solitary and social smiles. Biol Psychol (2003) 1.20

"Intuitive" lie detection of children's deception by law enforcement officials and university students. Law Hum Behav (2004) 1.17

CASME II: an improved spontaneous micro-expression database and the baseline evaluation. PLoS One (2014) 1.08

The effects of alcohol on the emotional displays of Whites in interracial groups. Emotion (2013) 0.99

Automatic decoding of facial movements reveals deceptive pain expressions. Curr Biol (2014) 0.99

"You can't kid a kidder": association between production and detection of deception in an interactive deception task. Front Hum Neurosci (2012) 0.96

Deceptively simple … The "deception-general" ability and the need to put the liar under the spotlight. Front Neurosci (2013) 0.84

How private is private information? The ability to spot deception in an economic game. Exp Econ (2016) 0.83

Robust Full-Motion Recovery of Head by Dynamic Templates and Re-registration Techniques. Int J Imaging Syst Technol (1) 0.80

Individual differences in the recognition of enjoyment smiles: no role for perceptual-attentional factors and autistic-like traits. Front Psychol (2011) 0.80

Younger and Older Users' Recognition of Virtual Agent Facial Expressions. Int J Hum Comput Stud (2015) 0.77

Deception Detection in Action: Embodied Simulation in Antisocial Human Interactions. Front Psychol (2017) 0.75

Hiding true emotions: micro-expressions in eyes retrospectively concealed by mouth movements. Sci Rep (2016) 0.75

Culture moderates changes in linguistic self-presentation and detail provision when deceiving others. R Soc Open Sci (2017) 0.75

Articles by these authors

(truncated to the top 100)

Constants across cultures in the face and emotion. J Pers Soc Psychol (1971) 4.78

Autonomic nervous system activity distinguishes among emotions. Science (1983) 3.50

Approach-withdrawal and cerebral asymmetry: emotional expression and brain physiology. I. J Pers Soc Psychol (1990) 2.85

Pan-cultural elements in facial displays of emotion. Science (1969) 2.60

Voluntary facial action generates emotion-specific autonomic nervous system activity. Psychophysiology (1990) 2.38

Behavioral markers and recognizability of the smile of enjoyment. J Pers Soc Psychol (1993) 2.28

Nonverbal leakage and clues to deception. Psychiatry (1969) 2.06

Measuring facial expressions by computer image analysis. Psychophysiology (1999) 1.84

Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosomes Cancer (1991) 1.61

Emotion, physiology, and expression in old age. Psychol Aging (1991) 1.59

Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract. Cell Microbiol (2001) 1.50

The symmetry of emotional and deliberate facial actions. Psychophysiology (1981) 1.33

Emotion and autonomic nervous system activity in the Minangkabau of west Sumatra. J Pers Soc Psychol (1992) 1.21

Allelotyping of human prostatic adenocarcinoma. Genomics (1991) 1.16

Estrogen receptors in human prostate: evidence for multiple binding sites. J Clin Endocrinol Metab (1983) 1.14

Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate (1992) 1.14

Linkages between facial expressions of anger and transient myocardial ischemia in men with coronary artery disease. Emotion (2001) 1.12

A randomized prospective study comparing long-term intravesical instillations of mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma. J Urol (1996) 1.10

Comparative kinetic studies on the L-type pyruvate kinase from rat liver and the enzyme phosphorylated by cyclic 3', 5'-AMP-stimulated protein kinase. Biochim Biophys Acta (1976) 1.07

Nucleostemin mRNA is expressed in both normal and malignant renal tissues. Br J Cancer (2006) 1.07

Lie detection and language comprehension. Nature (2000) 1.03

Is the startle reaction an emotion? J Pers Soc Psychol (1985) 1.02

Model studies on iron(III) ion affinity chromatography. II. Interaction of immobilized iron(III) ions with phosphorylated amino acids, peptides and proteins. J Chromatogr (1992) 0.98

Identification of two distinct deleted regions on chromosome 13 in prostate cancer. Oncogene (1998) 0.96

Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer. Clin Cancer Res (2001) 0.96

The asymmetry of facial actions is inconsistent with models of hemispheric specialization. Psychophysiology (1985) 0.95

Salmonella-triggered reactive arthritis: use of polymerase chain reaction, immunocytochemical staining, and gas chromatography-mass spectrometry in the detection of bacterial components from synovial fluid. Arthritis Rheum (1999) 0.94

Subtilisin-catalyzed removal of phosphorylated site of pig liver pyruvate kinase without inactivation of the enzyme. FEBS Lett (1975) 0.91

Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer. Genes Chromosomes Cancer (1999) 0.91

Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene (1994) 0.91

Tumour markers as prognostic aids in prostatic carcinoma. Br J Urol (1990) 0.91

Glucagon-induced phosphorylation of pyruvate kinase (type L) in rat liver slices. Biochem Biophys Res Commun (1977) 0.90

Head and body cues in the judgment of emotion: a reformulation. Percept Mot Skills (1967) 0.89

Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia. Eur Urol (1992) 0.89

Increased phosphate content of fibrinogen in vivo correlates with alteration in fibrinogen behaviour. Thromb Res (1992) 0.88

Differential communication of affect by head and body cues. J Pers Soc Psychol (1965) 0.88

Interstitial cystitis: correlation with nerve fibres, mast cells and histamine. Br J Urol (1993) 0.88

Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria. An experimental and clinical study. Eur Urol (1990) 0.88

Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group. Urology (1995) 0.87

What you say and how you say it: the contribution of speech content and voice quality to judgments of others. J Pers Soc Psychol (1985) 0.86

Proteolytic modification of pig and rat liver pyruvate kinase type L including phosphorylatable site. Biochim Biophys Acta (1978) 0.86

A behavioral phenotype in the de Lange syndrome. Pediatr Res (1976) 0.85

Epidemiology of high-grade prostatic intraepithelial neoplasia. Scand J Urol Nephrol Suppl (2000) 0.85

Amino acid sequence at the phosphorylated site of rat liver fructose-1,6-diphosphatase and phosphorylation of a corresponding synthetic peptide. Biochem Biophys Res Commun (1979) 0.85

Amino acid sequence at the phosphorylated site of rat liver pyruvate kinase. Biochem Biophys Res Commun (1975) 0.85

Expression and localization of gastrin messenger RNA and peptide in spermatogenic cells. J Clin Invest (1990) 0.84

Steroid receptor content in human prostatic carcinoma and response to endocrine therapy. Cancer (1979) 0.84

Tissue polypeptide antigen (TPA), some cytokeratins and epithelial membrane antigen (EMA) in normal, inflamed and malignant urothelium. Urol Res (1987) 0.83

Demonstration of a progestin receptor in human benign prostatic hyperplasia and prostatic carcinoma. Invest Urol (1978) 0.82

Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade. Anticancer Res (2002) 0.82

How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology (1997) 0.82

Urease-induced precipitation on latex and silver coated latex in vitro. Scand J Urol Nephrol Suppl (1991) 0.81

Detection and identification of substrates for protein kinases: use of proteins and synthetic peptides. Methods Enzymol (1984) 0.81

Invasion of Salmonella into human intestinal epithelial cells is modulated by HLA-B27. Rheumatology (Oxford) (2002) 0.81

Facial expression and the affective component of cynical hostility in male coronary heart disease patients. Health Psychol (1998) 0.80

A tool for the analysis of motion picture film or video tape. Am Psychol (1969) 0.80

Steroid receptor profile and receptor stability in subfractions of human prostatic tissues. Critical aspects on microassays. Urol Res (1991) 0.80

Simultaneous measurement of progesterone and androgen receptors in human prostate: a microassay. J Clin Endocrinol Metab (1982) 0.80

In vitro phosphorylation of serum albumin by two protein kinases: a potential pitfall in protein phosphorylation reactions. Anal Biochem (1986) 0.80

Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancer. Prostate (1998) 0.79

Pseudomonas aeruginosa: adherence to and growth on different urinary catheter coatings. Int Urol Nephrol (1990) 0.79

Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. II. Prognostic importance. J Urol (1991) 0.79

Substrate specificity of protein kinase C studied with peptides containing D-amino acid residues. J Biochem (1993) 0.79

Recessive genetic mechanisms in the oncogenesis of prostatic carcinoma. Scand J Urol Nephrol Suppl (1991) 0.79

Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer. Cancer Genet Cytogenet (1994) 0.79

Fructose-1,6-bisphosphatase from rat liver. A comparison of the kinetics of the unphosphorylated enzyme and the enzyme phosphorylated by cyclic AMP-dependent protein kinase. J Biol Chem (1985) 0.79

Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer. Eur Urol (2000) 0.79

Tissue polypeptide antigen (TPA) as a prognostic aid in human prostatic carcinoma. Prostate (1985) 0.79

In vitro phosphorylation of human complement factor C3 by protein kinase A and protein kinase C. Effects on the classical and alternative pathways. J Biol Chem (1990) 0.78

Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study. Br J Urol (1997) 0.78

Rapid proteolytic removal of phosphopeptides and phosphorylatable sites from proteins in rat liver cell sap. FEBS Lett (1978) 0.78

Facial areas and emotional information. J Commun (1975) 0.78

Rare association of unilateral renal oncocytoma and angiomyolipoma. Scand J Urol Nephrol (1997) 0.78

Assessment of prostatic size with computed tomography. Methodologic aspects. Acta Radiol Diagn (Stockh) (1982) 0.78

Influence of the nervous system on experimentally induced urethral inflammation. Neurosci Lett (1990) 0.78

Correlation between clinical response to hormone therapy and steroid receptor content in prostatic cancer. Cancer Res (1978) 0.78

The kinetics of unphosphorylated, phosphorylated and proteolytically modified fructose bisphosphatase from fat liver. Biochim Biophys Acta (1981) 0.78

Current concepts in the management of testicular germ cell tumours in adults. A review. Int J Androl (1982) 0.78

Spontaneous facial expression of emotions in brain-damaged patients. Cortex (1988) 0.78

The effect of fructose 2,6-bisphosphate and AMP on the activity of phosphorylated and unphosphorylated fructose-1,6-bisphosphatase from rat liver. FEBS Lett (1984) 0.78

Peptide fragments of myelin basic protein as substrates of protein kinase C. Biochem Int (1992) 0.78

Microassays for androgen and progesterone receptor quantitation as compared with standard saturation analyses in human prostatic tissues. Urol Res (1991) 0.78

Protein kinase C phosphorylates two of the four known syndecan cytoplasmic domains in vitro. Biochem Mol Biol Int (1995) 0.77

The similiarity of facial expressions in response to emotion-inducing films in reared-apart twins. Psychol Med (2007) 0.77

Asymmetry in facial expression. Science (1980) 0.77

The contribution of epinephrine to experimentally induced urethral inflammation in the rat. Neurosci Lett (1992) 0.77

Steroid receptor content in cytosol from normal and hyperplastic human prostates. J Clin Endocrinol Metab (1979) 0.77

The autonomic and behavioral profile of emotional dysregulation. Neurology (2004) 0.77

A potential pitfall in protein kinase assay: phosphocellulose paper as an unreliable adsorbent of produced phosphopeptides. Anal Biochem (1992) 0.77

The role of chromosome 8p22 deletion for predicting disease progression and pathological staging in prostate cancer. Aktuelle Urol (2003) 0.76

Germline mutations detected in the von Hippel-Lindau disease tumor suppressor gene by Southern blot and direct genomic DNA sequencing. Hum Mutat (1998) 0.76

Posed emotional expression in unilateral brain damaged patients. Cortex (1989) 0.76

Imitation of facial movements in brain damaged patients. Cortex (1987) 0.76

Iodine-125 brachytherapy for clinically localized prostate cancer: a 5-year follow-up of outcome and complications. Eur Urol (1994) 0.76

Molecular genetics and human prostatic carcinoma. Acta Oncol (1991) 0.76

Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. I. Histological description. J Urol (1991) 0.76

Purification of a Ca2+-activated protease from rat erythrocytes and its possible effect on pyruvate kinase in vivo. Biochim Biophys Acta (1981) 0.76

Serum levels of neopterin as related to the prognosis of human prostatic carcinoma. Eur Urol (1986) 0.76

Serum levels of prostatic acid phosphatase (PAP), tissue polypeptide antigen (TPA), CA-50, neopterine and of osteocalcin in patients with prostatic carcinoma. Scand J Clin Lab Invest Suppl (1985) 0.75

Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma. Urol Res (1989) 0.75